<DOC>
	<DOC>NCT00423605</DOC>
	<brief_summary>The objective of this trial is to evaluate the safety and efficacy of Xyrem® in long term use.</brief_summary>
	<brief_title>Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.</brief_title>
	<detailed_description>The trial is an open-label safety and efficacy study of subjects with fibromyalgia who completed either study 06-008 or 06-009. Total duration is up to 40 weeks of trial participation.</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Sodium Oxybate</mesh_term>
	<criteria>Subject has qualified for and completed either study 06009 (NCT00423813) or 06008 (NCT00371137). Subject is able, in the opinion of the investigator, to take Xyrem® for approximately 91/2 months. Subject terminated early from either study 06009 or 06008. Subject experienced any serious adverse event related to study drug in either study 06009 or 06008. Subject, in the opinion of the investigator, experienced an adverse event in 06009 or 06008 that may prevent him/her from safely participating in this study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>FMS</keyword>
	<keyword>Fibro</keyword>
	<keyword>Pain</keyword>
	<keyword>Body Pain</keyword>
	<keyword>Tenderness</keyword>
	<keyword>Joint pain</keyword>
	<keyword>Stiffness</keyword>
	<keyword>Muscular Pain</keyword>
</DOC>